A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration
Clinical trial NCT07489586 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07489586
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-12-01
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.